Answers are grounded in this paper and cite their sources.
It is important that consideration is given to possible adverse effects of some of the aforementioned interventions, which include the use of non-removable and removable knee-high offloading devices, and all surgical offloading procedures. These possible adverse effects, discussed later, should be discussed with the patient for informed shared decision-making. Foot ulcers are a major complication of diabetes mellitus and are associated with high morbidity, mortality, and costs 1-3. Yearly incidence is estimated to be around 2% in patients with diabetes 4, but this increases substantially when patients successfully heal from a foot ulcer, with reported recurrence rates between 30% and 40% in the first year 5, 6. Prevention and adequate treatment of these ulcers is therefore of paramount importance. Peripheral neuropathy affects approximately half of people with diabetes mellitus and leads to loss of protective sensation in the feet, which is one of the most important risk factors for ulceration 3, 7. In the presence of loss of protective sensation, elevated levels of mechanical pressure can contribute to the development of foot ulcers in diabetic patients 7-9. High foot pressure is itself significantly associated with foot deformity and structural changes in soft tissue 10. From this, it can be inferred that the combination of foot deformity, loss of protective sensation, inadequate offloading, and a minor trauma leads to tissue damage and ulceration. And once an ulcer has formed, healing may be chronically delayed, if the area is not effectively offloaded. There is a long clinical tradition in the use of casting, footwear, surgery, and other offloading techniques for the prevention and healing of foot ulcers in patients with diabetes. Previous reviews have shown that sufficient evidence is available to support the use of non-removable offloading techniques to heal plantar forefoot ulcers 11-13, but that more high-quality studies are needed to confirm promising effects of other offloading interventions to prevent and heal foot ulcers, in order to better inform clinicians and practitioners about effective treatment 11. Over the last few years, several well-designed controlled studies have been performed to meet this goal. In this guidance document, recommendations are given for each of the previously listed intervention groups, and include the rationale for how we arrived at a recommendation. ‡ This rationale was based on available evidence from a systematic review of the literature 14, expert opinion where evidence is not available, the consideration of benefits and harm, patients' values and preferences, and costs related to the intervention. Two high-quality systematic reviews and meta-analyses of randomized and non-randomized controlled trials indicate that the use of non-removable offloading devices [both total contact casting (TCC) and walkers rendered irremovable] results in a significantly higher proportion of healed diabetic neuropathic plantar forefoot ulcers when compared with removable offloading devices (including both walkers and footwear) 12, 13. A Cochrane systematic review and meta-analysis included five randomized controlled trials (RCTs) 15-19 with a cumulative total of 230 patients and found a relative risk ratio of 1.17 [95% confidence interval (CI) 1.01–1.36, p = 0.04] for non-removable offloading to achieve healing compared with removable offloading 12. Another systematic review and meta-analysis included ten randomized and non-randomized clinical studies with a cumulative total of 524 patients 15-17, 19-25 and showed a significantly higher relative risk ratio of 1.43 (95% CI 1.11–1.84, p = 0.001) for non-removable offloading to achieve healing compared with removable offloading 13. Based on two relatively small RCTs 18, 26, there is evidence to suggest that a removable walker rendered irremovable is as effective as a TCC in healing neuropathic plantar forefoot ulcers (Relative risk ratio = 1.06; 95% CI 0.88–1.27, p = 0.31) 13. Therefore, there is no particular preference for a TCC or prefabricated non-removable knee-high device to heal plantar foot ulcers, as long as an appropriate foot–device interface is maintained. We conclude that the quality of evidence is high. Possible adverse effects of non-removable knee-high devices include ankle joint immobilization, reduced activity level, potential risk of falls, knee or hip complaints due to asymmetry in walking from the unilaterally increased sole height, and pressure ulcers due to poor casting or fitting 16, 27, 28. Nevertheless, we consider the benefits of effective and expedited healing to outweigh such potential harm. Many patients may prefer not to use a non-removable knee-high device as it limits them in their daily life, for example, with sleeping, bathing, or driving a car. Practitioners may also see several barriers to the application of non-removable offloading, as surveys and epidemiological studies show only limited use of the TCC in clinical practice 29, 30. Cost-effectiveness has not been assessed to date. One study showed, however, that, while only 6% of patients with a foot ulcer were treated with a TCC, the average cost of treatment of these patients was half of that incurred by patients who were not treated with a TCC 31. A systematic review and meta-analysis, including ten randomized and non-randomized clinical studies and a cumulative total of 524 patients 15-17, 19-25, showed significantly better healing for non-removable offloading compared with removable offloading (RR 1.43; 95% CI 1.11–1.84, p = 0.001) 13. However, stratified by type of removable device, five RCTs 15-17, 19, 23 found a trend but no statistically significant difference between non-removable knee-high offloading devices and removable knee-high walkers (RR = 1.23, 95% CI 0.96–1.58, p = 0.085) 13. Based on the availability of five RCTs, and wide CI around the point estimator of relative risk (suggesting inconsistency), we conclude that the quality of evidence is moderate. Possible adverse effects of knee-high removable devices include ankle joint immobilization, reduced activity level, potential risk of falls, or knee or hip complaints due to asymmetry in walking from the unilaterally increased sole height. Nevertheless, we consider the benefits of effective treatment to outweigh the potential harm. Patients may value and prefer the use of a removable knee-high offloading device, as it is more practical than non-removable offloading for activities such as bathing, sleeping, and driving a car. However, the possibility of non-adherence should always be considered, as one study showed that patients with active ulcers who are prescribed with a removable walker wore their device only 28% of the steps that they took 33. Practitioners may also prefer a removable walker over a TCC, as the former does not require a skilled technician to apply the device. Furthermore, wound care and inspection can take place at any time with a removable device, not only when devices are replaced such as with non-removable offloading. Costs are considered to be relatively high for many of the available removable knee-high walkers but should always be considered with respect to efficacy in healing; cost-effectiveness has not been reported to date. Several non-controlled studies show that 70–96% of plantar foot ulcers can be healed in a reasonable time frame (mean 34–79 days) with ankle-high removable offloading shoes such as cast shoes, half-shoes, and forefoot offloading shoes 34-38. These outcomes are comparable with those found with TCC. However, in the only controlled study on this topic, half-shoes have shown to be inferior to the TCC 16. The use of custom-made temporary shoes for healing relatively large and deep ulcers, some with mild infection, in neuropathic patients of which many had moderate PAD, was examined in one RCT at low risk of bias. The study found relatively low healing proportions, and equivalence in healing proportion and reduction in ulcer area between the temporary shoes and a TCC 21. Based on the limited number of controlled studies, the quality of evidence is low. The benefits of treatment with ankle-high offloading shoes compared with other ankle-high modalities such as conventional shoes will likely outweigh potential harm, but compared with knee-high devices, the lower efficacy and/or longer healing times associated with such interventions poses a higher risk for infection and hospitalization. The traditional form of half-shoes, that only support the midfoot and heel 37, are contraindicated owing to risk of midfoot fracture. Patients may prefer to use an ankle-high modality over a knee-high device to promote walking and among ankle-high modalities likely prefer a comfortable cast shoe or custom-made temporary shoe over a half-shoe or forefoot offloading shoe, because the latter has a significant negative rocker outsole that may cause balance problems during gait. The cost of treatment is relatively low for forefoot offloading shoes and cast shoes, both requiring no replacement during treatment. Costs for custom-made temporary shoes are higher; cost-effectiveness has not been reported. One RCT with high risk of bias showed a positive effect of therapeutic footwear over no footwear prescription in at-risk patients, most of which had no ulcer history, to prevent ulcer incidence 39. Another RCT with high risk of bias showed a clear trend, but no significant effect of shear-reducing insoles on preventing foot ulcers 40. A third RCT at very low risk of bias showed that digital silicone orthoses can significantly reduce first ulcer incidence in at-risk patients with pre-ulcerative lesions 41. Relative risk reduction for use of the intervention varied between 69.8% and 92.9% in these studies, although the 95% CIs show that effect may vary for individual patients. There are no controlled studies that specifically investigate the effect of therapeutic footwear on the prevention of non-plantar lesions. However, ill-fitting footwear has been identified as an important cause of non-plantar ulcers 42, suggesting that properly fitting footwear can protect against ulceration. In properly fitting footwear, the shoe should not be either too tight or too loose. The inside of the shoe should be 1–2 cm longer than the foot. The internal width should equal the width of the foot at the metatarsal-phalangeal joints (or the widest part of the foot), and the height should allow enough room for all the toes. Evaluate the fit with the patient in the standing position, preferably at the end of the day. Those patients with a foot deformity or a pre-ulcerative sign may need further adaptations to their footwear, which may include therapeutic footwear, custom-made insoles, or a toe orthosis. Based on the small number of RCTs, on a wide range of interventions, the quality of evidence is low. Two RCTs with very low risk of bias show that therapeutic footwear that has proven to effectively offload the foot can significantly reduce the risk for a recurrent plantar foot ulcer. One of the trials was specific to metatarsal head ulcers, and in the other trial, the effect required adherence to wearing the footwear 6, 43. Effect sizes were large (46.1–63.6% relative risk reduction compared with standard of care therapeutic footwear), but 95% CIs show that effect may vary across patients. These data confirm earlier findings in three RCTs with mixed methodological quality on the efficacy of therapeutic footwear (relative risk reductions compared with control condition: 52.5–70.2%) 39, 40, 44. One other RCT at low risk of bias assessed the effect of therapeutic insoles and showed no significant effect on ulcer recurrence compared with standard footwear (relative risk reduction 12%) 45. However, the latter study did not use insoles with proven efficacy in offloading plantar pressure. Based on the availability of several trials at very low or low risk of bias, some inconsistency in findings between trials, and large CIs around effect size, we conclude that the quality of evidence is moderate. The benefits of continuously wearing footwear with a proven offloading effect outweigh the potential harm, as few footwear-related complications are reported in these trials. Patients may value the use of therapeutic footwear to protect their feet against ulcer recurrence, but often, patients do not wear the footwear, especially when at home 46. Some patients may not know that their prescribed footwear should also be worn inside the house. Such patients should be correctly informed about the purpose and value of their therapeutic footwear and be motivated to continuously wear the footwear 47. Other patients may prefer not to wear their therapeutic footwear at home because they find their shoes heavy, bulky, dirty, difficult to don and doff, or for religious reasons. In such cases, prescription of an additional pair of offloading footwear specifically for indoor use may be a useful solution, although evidence is currently lacking 46. The costs of prescribing therapeutic footwear with demonstrated offloading effect may be quite high as it requires the measurement of barefoot or in-shoe plantar pressure for which equipment to date can be relatively expensive. However, these costs should always be regarded in association with the benefit for ulcer prevention; cost-effectiveness has not been studied to date, but, in our opinion, footwear designed or evaluated using plantar pressure measurement will likely be cost-effective when it reduces risk of ulcer recurrence by 50%, as was found in most trials on this topic. This recommendation is predicated on the availability of both therapeutic footwear and technology for pressure measurement. Not in all regions and clinical settings, however, plantar foot pressure can be measured. For these cases, we recommend to prescribe therapeutic footwear using available state-of-the-art scientific knowledge on footwear designs that effectively offload the foot. There are no studies that show the efficacy of conventional or standard therapeutic shoes to heal neuropathic plantar foot ulcers. In the few studies in which this footwear has been tested as comparison condition, the footwear proved inferior to other offloading devices 20. There is no evidence available on how to treat non-plantar foot ulcers, even though such lesions often also need relief from mechanical stress. Depending on the location of the ulcer, various modalities can be considered, including shoe modifications, temporary footwear, toe spacers, and orthoses. Temporary footwear does not have to be custom made but can consist of properly fitting standard therapeutic footwear that prevents direct contact with the ulcer. Based on expert opinion, we expect the benefits of the use of these modalities to outweigh any potential harm such as lesions caused by the footwear or orthoses. Patients will likely value the use of these modalities and prefer them for treatment of their non-plantar foot ulcers. Costs for applying these modalities are relatively low. One RCT with low risk of bias and several non-controlled studies show the positive effect of ATL, performed primarily to heal recalcitrant forefoot plantar ulcers, in preventing ulcer recurrence 48-54. Relative risk reductions over conservative treatment were 75% and 52% at 7 months and 2 years, respectively 48. One small RCT with low risk of bias 55, two retrospective cohort studies with varying risk of bias 56, 57, and several non-controlled studies 58-61 found efficacy of single or pan metatarsal head resections to prevent ulcer recurrence. The controlled studies showed relative risk reductions between 61.1% and 83.8% over conservative treatment. Two small retrospective cohort studies with high risk of bias and three non-controlled studies showed low ulcer recurrence rates after metatarsal-phalangeal or inter-phalangeal joint arthroplasty 62-66. One of the cohort studies showed a relative risk reduction of 83.6% compared with conservative treatment. One retrospective cohort study on osteotomy showed a 60% but non-significant reduction in ulcer recurrence compared with conservative treatment, while one non-controlled study showed no ulcer recurrence after osteotomy 67, 68. While effect sizes are often large, only few controlled studies per intervention show the efficacy of these surgical approaches. Furthermore, these surgical procedures apply to selected patients only: for all mentioned surgical procedures, they apply to those patients that fail conservative treatment for an active foot ulcer and who are considered at very high risk if foot structure is not permanently changed. Furthermore, ATL applies only to patients with limited ankle dorsiflexion. Considering the small number of controlled studies and the often high risk of bias in the studies on surgical offloading, we conclude that the quality of evidence is low. Seven retrospective case series of percutaneous digital flexor tendon tenotomy performed in patients primarily to heal distal toe ulcers reported a recurrence rate after healing of between 0% and 20% over a mean follow-up of between 11 and 36 months in a cumulative total of 231 treated patients 71-77. Four of the seven studies also reported on the effects of digital tenotomy of a toe where no ulcer was present at the time of the procedure. In a cumulative total of 58 patients with impending ulcers (i.e. callus on the tip of the toe), there was no reported ulcer occurrence in a mean 11- to 31-month follow-up 73-75, 77. While controlled studies on this topic are lacking, we consider this a promising procedure, to prevent both first and recurrent ulcers, in patients with pre-ulcerative lesions that fail conservative treatment. This is based on the low incidence rates found, our expert opinion, and results from healing studies. The quality of evidence is nevertheless low. The possible benefits of digital flexor tenotomy likely outweigh the harm; very few complications have been reported. Patients who have pre-ulcerative lesions for which they have frequent conservative treatment that does not improve outcome may value and prefer treatment by flexor tenotomy. Furthermore, flexor tenotomy is easily performed in an outpatient setting, with no need for subsequent immobilization, and is not likely to negatively affect foot function. Costs and cost-effectiveness of this procedure have not been evaluated. One RCT with low risk of bias found small effects on proportion ulcers healed (14% more) and time to healing (29% shorter) of plantar forefoot ulcers using ATL in addition to TCC compared with TCC alone in selected patients with reduced ankle dorsiflexion range of motion 48. Four retrospective non-controlled studies showed 80–95% healing in 3 months by ATL 51-54. One RCT at low risk of bias, two retrospective cohort studies, and six retrospective or prospective non-controlled studies show positive effects of single or pan metatarsal head resection in time to healing of plantar neuropathic metatarsal head ulcers compared with conservative treatment, often in patients in whom conservative treatment was not successful 55-61, 69, 78. The controlled studies showed a relative increase in the proportion of healed ulcers by resection of 21% 55, and a shorter time to healing of 29–64% 55-57. A case–control study and a cohort study on the efficacy of metatarsal-phalangeal joint arthroplasty in addition to TCC to heal sub-inter-phalangeal joint ulcers showed a significantly shorter time to healing by 51–64% in the arthroplasty group 62, 63. Thus, there is some evidence to support these surgical interventions compared with conservative treatment to improve time to healing (but not convincingly for healing proportions) of plantar foot ulcers in selected patients after non-successful conservative treatment. Based on the low number of controlled studies for each intervention, the quality of evidence is low. Seven retrospective case series of percutaneous digital flexor tendon tenotomy performed in patients with the goal of healing distal toe ulcers showed in a cumulative total of 231 treated patients that 92–100% ulcers healed in a mean time to healing of 21–40 days, with a low rate of reported complications 71-77. While controlled studies on this topic are lacking, we consider this procedure to be a promising intervention in patients with hammertoes and recalcitrant toe ulcers that fail conservative treatment. The quality of evidence is low. The possible benefits of digital flexor tenotomy likely outweigh the potential harm as very few complications have been reported. Patients who have toe ulcers that will not heal with conservative treatment may value and prefer treatment by flexor tenotomy, which is easily performed in an outpatient setting, without need for subsequent immobilization, and is not likely to negatively affect foot function. Costs and cost-effectiveness of this procedure have not been evaluated. Two RCTs with high risk of bias and one retrospective cohort study examined the effect of felted foam in ulcer healing. One RCT showed significantly shorter time to healing with felted foam worn in a post-operative shoe when compared with a pressure relief half-shoe used without the felted foam 79. Another RCT showed no difference in healing proportion or time to healing between felt fitted to the foot compared with felt fitted to temporary therapeutic footwear 80. Felted foam worn in a surgical shoe, a healing shoe, or a walking splint was reported to be as effective as a TCC in both healing proportion and time to healing 36. Based on the lack of well-designed controlled studies, and the difficulty in determining the added effect of felted foam in the studies performed, the quality of evidence is low. Any benefit found with the use of felted foam will likely outweigh the harm, as studies of felted foam have reported no complications. Patients will likely value and prefer the use of felted foam as an easy-to-use, non-limiting modality. The costs of felted foam are relatively low, but it does require frequent replacement, by the patient, a relative, or a home-care nurse. Based on the evidence from the studies performed, felted foam should only be used in addition to appropriate footwear, walkers, or cast, and not as a single treatment modality. PRC owns stocks in DIApedia and is an inventor on US patents 6,610,897, 6,720,470, and 7,206,718 that describe a load-relieving dressing and a method of insole manufacture for offloading diabetic feet. SB, RvD, DGA, JL, and CC have no conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Bus et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: